World’s most extensive skin quality profiling survey of more than 11,000 people across Europe, Asia, and the Americas finds that nine out of ten people are affected by skin quality concerns, with the most important attributes of good skin quality identified as smooth, hydrated and glowing skin1
Results show that skin quality has an impact on quality of life for 85% of people, with more than a third feeling self-conscious, insecure or anxious due to poor skin quality1
In response to clinicians’ calls for a universal assessment tool to help address these concerns, Galderma supported leading experts in the development of the Skin Quality Assessment Scale; a holistic, science-based tool to evaluate skin quality comprehensively and guide personalized, long-term treatment planning2
At Galderma, we champion skin quality by providing insights, tools, and solutions to better understand and address a wide spectrum of concerns, helping people take pride and feel comfortable in their own skin at every stage of life

Galderma (SWX:GALD) has unveiled results from the world’s most extensive skin quality profiling survey, finding that skin quality concerns are widespread, can impact emotional wellbeing and, while differing based on the individual, are often similar among people alike in age, lifestyle, and environment.1 These results underscore the need for effective solutions that can be tailored to a wide variety of skin quality concerns.

Key findings:1

• Nine out of ten people globally are affected by skin quality concerns, with each person experiencing an average of two concerns in the past month
• The most common concerns are fine lines and wrinkles (41%), dry skin (40%), and dull skin (37%), most frequently affecting the face
• Skin quality impacts quality of life for 85% of people, with more than one in three reporting feelings of self-consciousness, insecurity or anxiety

Skin quality refers to how the skin looks, feels and functions on a day-to-day basis, including its hydration, elasticity, smoothness, radiance, firmness and tone.2 As we age and due to external factors, such as stress, diet, sun exposure, lack of sleep, pollution, or medication-driven weight loss, the amount and quality of the three main components of the skin – hyaluronic acid, elastin and collagen – decrease, leading to a deterioration in skin quality.1,3-6 This is often influenced by geography and culture, and can be accelerated at certain life stages, such as during the menopause, because of hormonal changes.3,4,6,7 Skin quality deterioration reflects visibly across the skin, through a rough or dry texture, an uneven skin tone, or a loss of radiance or firmness.2,3

To gain a detailed understanding of how people perceive skin quality and the concerns that matter most to them, Galderma conducted a survey of more than 11,000 people across 11 countries in four continents: Canada, the United States, Brazil, China, Korea, Thailand, India, France, Germany, Italy, and the United Kingdom. Results showed that skin quality concerns are highly prevalent and important, with nine out of ten people affected and each person experiencing an average of two concerns within the past month.1 The main concerns were fine lines and wrinkles, dry skin, and dull skin – experienced by 41%, 40% and 37% of people, respectively.1 Additionally, age spots, oily skin, decreased firmness and enlarged pores emerged as notable concerns.1 These were found to primarily affect the face, followed by the neck, legs and upper arms.1 Conversely, the most important attributes of good skin quality were smooth, hydrated and glowing skin.1

One in three people feel insecure or anxious due to skin quality concerns1
Skin quality affects more than appearance, influencing emotional wellbeing and shaping how comfortably and confidently people present themselves in their lives.2 Survey results showed that, for 85% of people, skin quality has an impact on their quality of life, with more than a third feeling self-conscious, insecure or anxious due to poor skin quality.1 All skin concerns were described as bothersome, with the most bothersome being scarring, including due to acne, followed by fine lines and wrinkles.1

This discomfort leads most people to either consider or actively seek ways to address skin quality concerns, in particular younger consumers.1 Approximately 70% of 18-34 year olds rated skin quality as eight out of ten in importance, with people most likely to take the first steps to improve the skin quality of their face at the age of 26.1 Respondents were most satisfied with hyaluronic acid injectables as treatments for the most common skin quality concerns of lines and wrinkles (86% very satisfied), dry skin (85%) and dull skin (82%).1

Addressing patient concerns with the innovative Skin Quality Assessment Scale
To support the accurate assessment and treatment of skin quality concerns, Galderma brought together global dermatology experts to develop the Skin Quality Assessment Scale, the first holistic skin quality assessment tool of its kind.2 The scale helps identify treatment priorities, align expectations, support personalized long-term treatment planning, and track progress over time.2 It was created in response to a clear need identified by healthcare professionals: in a global clinician study, nearly two thirds reported not using any formal tool to assess skin quality, while 81% believed a simple, holistic assessment approach was missing in clinical practice.2 Following its development, 100% of participating clinicians agreed that the Skin Quality Assessment Scale supports a holistic understanding of skin quality, with 98% confirming that it helps guide treatment planning.2

With its decades of expertise in dermatology and aesthetics, and one of the broadest and most diverse portfolios, Galderma is uniquely positioned to address a range of skin quality concerns. Treatments such as Sculptra® and Restylane® Skinboosters™ work together to support skin quality by stimulating collagen and elastin production and enhancing hydration, respectively, helping to improve skin firmness, smoothness and overall radiance.8-17 Galderma designed the Glow on Holistic Individualized Treatment (HIT™) approach to support aesthetic practitioners in combining these two treatments to improve skin quality. Galderma’s Dermatological Skincare flagship brands, Alastin® and Cetaphil®, can also address a broad range of skin quality needs.18-24 The versatile Alastin range is made up of peri-procedural and daily skincare that supports the skin’s regeneration process to help restore a youthful appearance and enhance the visible outcomes of aesthetic and surgical procedures, whereas Cetaphil is designed for those with sensitive skin to help restore, protect and maintain the skin's health every day, building longevity and resilience over time.18-24

Read this report to find out more about how Galderma’s insights, tools, and solutions can support people at every step of their skin quality journey. More insights into the survey results can be found in this infographic.

About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

References

1. Galderma. Data on file. Skin Quality Consumer Survey.
2. Martschin C, et al. Development and validation of a novel holistic Skin Quality Assessment Scale. J Cosmet Dermatol. 2025;24(1):e16615. doi: 10.1111/jocd.16615.
3. Zhang S, Duan E. Fighting against Skin Aging. Cell Transplant. 2018;27(5):729-738. doi: 10.1177/0963689717725755.
4. Hussein RS, et al. Influences on skin and intrinsic aging: biological, environmental, and therapeutic insights. J Cosmet Dermatol. 2024;24(2):e16688. doi: 10.1111/jocd.16688.
5. Humphrey CD, Lawrence AC. Implications of Ozempic and other GLP-1 receptor agonists for facial plastic surgeons. Facial Plast Surg. 2023;39(6):719–721. doi: 10.1055/a-2148-6321.
6. Chylińska N and Maciejczyk M. Hyaluronic acid and skin: its role in aging and wound-healing processes, Gels. 2025;11(4):281. doi: 10.3390/gels11040281.
7. Reilly DM, Lozano J. Skin collagen through the lifestages: importance for skin health and beauty. Plast Aesthet Res. 2021;8:2. doi: 10.20517/2347-9264.2020.153.
8. Nikolis A, et al. A comprehensive interim analysis of skin hydration, barrier function (TEWL), elasticity, and patient satisfaction across two treatment arms. Interim Data on File. April 2026.
9. Waibel J, et al. A randomized, comparative study describing the gene signatures of poly-L-lactic acid (PLLA-SCA) and calcium hydroxylapaptite (CaHA) in the treatment of nasolabial folds. Poster presented at IMCAS World Congress; February 3-6, 2024; Paris, France.
10. Huth S, et al. Molecular insights into the effects of PLLA-SCA on gene expression and collagen synthesis in human 3d skin models containing macrophages. J Drugs Dermatol. 2024;23(4):285-288. doi: 10.36849/JDD.7791.
11. Sculptra®. EU Instructions for Use. 2025. Available online. Accessed June 2026.
12. Fabi S, et al. Effectiveness and safety of correction of cheek wrinkles using a biostimulatory poly-L-lactic acid injectable implant - clinical study data up to 24 months. Poster presented at IMCAS World Congress. January 26-28, 2023; Paris, France.
13. Bohnert K, et al. Randomized, controlled, multicentered, double-blind investigation of injectable poly-L-Lactic acid for improving skin quality. Plast Reconstr Surg. 2019;127(4):1684–1692. doi: 10.1097/DSS.0000000000001772.
14. Restylane® Skinboosters Vital Lidocaine™. IFU. August 2022. Available online. Accessed June 2026.
15. Restylane® Skinboosters Vital Light Lidocaine™. IFU. August 2021. Available online. Accessed June 2026.
16. Nikolis A, et al. Evaluating the role of small particle hyaluronic acid fillers using micro-droplet technique in the face, neck and hands: a retrospective chart review. Clin Cosmet Investig Dermatol. 2018;11:467–475. doi: 10.2147/CCID.S175408.
17. Streker M, et al. Stabilized hyaluronic acid-based gel of non-animal origin for skin rejuvenation: face, hand, and decolletage. J Drugs Dermatol. 2013;12(9):990–4. PMID: 24002145.
18. Gold M, et al. A multi-center clinical trial to evaluate the efficacy of the next generation TriHex Technology antiaging regimen. J Cosmet Dermatol. 2025;24(4):e70192. doi: 10.1111/jocd.70192.
19. Widgerow AD, et al. Extracellular matrix modulation: optimizing skin care and rejuvenation procedures. J Drugs Dermatol. 2016;15(Suppl 4):s63-s71. PMID: 27050707.
20. Widgerow AD, et al. Preoperative skin conditioning: extracellular matrix clearance and skin bed preparation, a new paradigm. Aesthet Surg J. 2019;39(Suppl_3):S103-S111. doi: 10.1093/asj/sjz022.
21. Galderma. Data on file. SPR.3540.207626.
22. Galderma. Data on file. SPR.3438.207553.
23. Galderma. Data on file. SPR.3438.207551.
24. Widgerow AD, et al. Novel strategy for strengthening dermatoporotic skin by managing cellular senescence. J Drugs Dermatol. 2024;23(9):748-756. doi: 10.36849/JDD.8388.

Contacts

For further information:

Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50

Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62

Céline Buguet
Franchises and R&D Communications Director
celine.buguet@galderma.com
+41 76 249 90 87

Emil Ivanov
Head of Strategy, Investor Relations, and ESG
emil.ivanov@galderma.com
+41 21 642 78 12

Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43

Skin quality infographic